OKSHOON SCOTT: Open Payments
NPI 1073963187 · CANTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,538 in 129 payments from 35 companies in 2025. Trend: 2023 $872 · 2024 $2,068 · 2025 $2,538
Food & beverage: $2,538
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $281 |
| Incyte Corporation | 17 | $208 |
| Merck Sharp & Dohme LLC | 8 | $182 |
| Janssen Biotech, Inc. | 12 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $116 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| ABBVIE INC. | 4 | $95 |
| Agios Pharmaceuticals, Inc. | 3 | $92 |
| PharmaEssentia USA Corporation | 4 | $90 |
Products named: JAKAFI, KEYTRUDA, EPKINLY, ICLUSIG, RYBREVANT, PYRUKYND, Fabhalta, BESREMI.
Industry payments across MS — which companies pay providers there.
